Vicapsys Life Sciences Inc (VICP)
US Market

Vicapsys Life Sciences (VICP) Income Statement


Vicapsys Life Sciences Income Statement

Last quarter (Q ), Vicapsys Life Sciences's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Vicapsys Life Sciences's net income was $-135.69K. See Vicapsys Life Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 09
Total Revenue
--$ 0.00$ 0.00$ 0.00$ 7.78M
Cost of Revenue
-----$ 7.24M
Gross Profit
-----$ 544.52K
Operating Expense
$ -423.11K$ 644.56K$ 336.87K$ 765.84K$ 1.03M$ 1.90M
Operating Income
$ -216.11K$ -644.56K$ -336.87K$ -765.84K$ -1.03M$ -1.35M
Net Non Operating Interest Income Expense
-----$ -320.59K
Other Income Expense
-$ -340.23K$ 100.00K--$ 4.32K
Pretax Income
$ -984.66K$ -984.79K$ -236.87K$ -765.84K$ -1.03M$ -1.67M
Tax Provision
$ -22.19K$ -22.19K-$ 0.00$ 0.00$ 0.00
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
$ -693.71K$ -988.34K$ -236.87K$ -765.84K$ -1.57M$ -1.67M
Basic EPS
$ -0.02$ -0.03-$ -0.10$ -0.13$ -4.80
Diluted EPS
$ 0.01$ -0.03-$ -0.10$ -0.13$ -4.80
Basic Average Shares
$ 100.48M$ 30.58M-$ 17.48M$ 11.40M$ 346.80K
Diluted Average Shares
$ 69.90M$ 30.58M-$ 17.48M$ 11.40M$ 346.80K
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
Rent Expense Supplemental
Total Expenses
$ -423.11K$ 644.56K$ 336.87K$ 765.84K$ 1.03M$ 9.14M
Net Income From Continuing And Discontinued Operation
$ -984.66K$ -984.79K$ -236.87K$ -765.84K$ -1.41M$ -1.67M
Normalized Income
$ -252.28K-$ -336.87K$ -765.84K$ -1.03M$ -1.67M
Interest Expense
-----$ 322.47K
$ -984.66K$ -984.79K$ -336.87K$ -765.84K$ -1.03M$ -1.35M
$ -967.62K$ -953.50K$ -305.54K$ -734.42K$ -1.00M$ -1.23M
Currency in USD

Vicapsys Life Sciences Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis